Xtant Medical Holdings Inc (NYSE American:XTNT)

7.30
Delayed Data
As of Feb 20
 +0.75 / +11.45%
Today’s Change
3.96
Today|||52-Week Range
14.52
+6.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$11.2M

Company Description

Xtant Medical Holdings, Inc. operates as a holding company, which supplies orthopedic and spine surgery products. The company operates through its subsidiaries, Bacterin International, Inc. and X-spine Systems, Inc. Bacterin International develops, manufactures, and markets biologics products to domestic and international markets. Its products are bone graft, which are used in promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries; and custom surgical products used for allografts. X-spine Systems is a manufacturer of implants and instruments for surgery of the spine and sacroiliac joint. Its products are used for the treatment of degenerative spine disorders. The company was founded in 2006 and is headquartered in Belgrade, MT.

Contact Information

Xtant Medical Holdings, Inc.
664 Cruiser Lane
Belgrade Montana 59714
P:(406) 388-0480
Investor Relations:

Employees

Shareholders

Other institutional558.37%
Individual stakeholders26.80%
Mutual fund holders0.29%

Top Executives

Carl D. O'ConnellPresident, Chief Executive Officer & Director
Anthony DeFalcoVice President-Product Development & Operations
Laura C. KendallChief Financial Officer
Gregory A. JudaChief Scientific Officer
David BakerChief Restructuring Officer